Journal
NATURE
Volume 443, Issue 7113, Pages 780-786Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nature05291
Keywords
-
Categories
Funding
- MRC [G0000872] Funding Source: UKRI
- Medical Research Council [G0000872] Funding Source: researchfish
- Medical Research Council [G0000872] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
Many late-onset neurodegenerative diseases, including Parkinson's disease and Huntington's disease, are associated with the formation of intracellular aggregates by toxic proteins. It is therefore crucial to understand the factors that regulate the steady-state levels of these 'toxins', at both the synthetic and degradation stages. The degradation pathways acting on such aggregate-prone cytosolic proteins include the ubiquitin - proteasome system and macroautophagy. Dysfunction of the ubiquitin - proteasome or macroautophagy pathways might contribute to the pathology of various neurodegenerative conditions. However, enhancing macroautophagy with drugs such as rapamycin could offer a tractable therapeutic strategy for a number of these diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available